Study of HL-1186 in healthy adults
Treatments studied
This study tests a new medicine called HL-1186 in healthy volunteers to see how safe it is and how the body handles it. If you join, you will help researchers gather early information that may lead to future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 45 years old.
- You weigh at least 110 pounds (50 kg) if male, or 99 pounds (45 kg) if female.
- Your body mass index (BMI) is between 19.0 and 26.0.
- You are not pregnant, breastfeeding, or planning to have children during the study.
- You do not have any long-term health conditions like heart, liver, or kidney disease, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called TLC-1180 in healthy volunteers to see how it works in the body. It's a first step to find a safe dose before studying it in people with illness.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.